EATBF yields 2567.39% · PFE yields 6.13%● Live data
📍 EATBF pulled ahead of the other in Year 1
Combined, EATBF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EATBF + PFE for your $10,000?
Eat & Beyond Global Holdings Inc. is a private equity and venture capital firm specializing in early stage, growth, expansion, buy-ins or buy-out investments. It focuses on investments in the plant-based protein and meat alternative food industry. It identifies and acquires equity in companies operating in the sectors of plant-based proteins, fermented proteins, cultured proteins/agriculture, food tech, and consumer packaged goods, as well as cell agriculture and other experimental projects. The firm prefers to invest in companies based in North America, Europe, Israel, and Asian and Latin American countries. It typically invests between $1 million and $10million over the initial 48-month deployment period with a minimum ownership goal of 5%+. It prefers to take majority stakes. Eat & Beyond Global Holdings Inc. was incorporated in 2019 and is headquartered in Vancouver, Canada.
Full EATBF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.